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Abstract Incorporation of viral DNA may interfere with
the normal sequence of human DNA bases on the genetic
level or cause secondary epigenetic changes such as gene
promoter methylation or histone acetylation. Colorectal
cancer (CRC) is the second leading cause of cancer
mortality in the USA. Chromosomal instability (CIN) was
established as the key mechanism in cancer development.
Later, it was found that CRC results not only from the
progressive accumulation of genetic alterations but also
from epigenetic changes. JC virus (JCV) is a candidate
etiologic factor in sporadic CRC. It may act by stabilizing
β-catenin, facilitating its entrance to the cell nucleus,
initialing proliferation and cancer development. Diploid
CRC cell lines transfected with JCV-containing plasmids
developed CIN. This result provides direct experimental
evidence for the ability of JCV T-Ag to induce CIN in the
genome of colonic epithelial cells. The association of CRC
hMLH1 methylation and tumor positivity for JCV was
recently documented. JC virus T-Ag DNA sequences were
found in 77% of CRCs and are associated with promoter
methylation of multiple genes. hMLH1 was methylated in
25 out of 80 CRC patients positive for T-Ag (31%) in
comparison with only one out of 11 T-Ag negative cases
(9%). Thus, JCV can mediate both CIN and aberrant
methylation in CRC. Like other viruses, chronic infection
with JCV may induce CRC by different mechanisms which
should be further investigated. Thus, gene promoter
methylation induced by JCV may be an important process
in CRC and the polyp-carcinoma sequence.
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Introduction
The association between chronic viral infection and human
malignancy is well established: papillomaviruses are involved
inthepathogenesis ofhumancervicalcancer(DellandGaston
2001), Epstein-Barr virus has been linked to Burkitt's
lymphoma, nasopharyngeal carcinoma, post-transplant lym-
phoma, Hodgkin's disease, and gastric carcinoma (Thompson
and Kurzrock 2004); hepatitis viruses B and C are associated
with hepatocellular carcinoma (Monto and Wright 2001),
Simian virus 40 has been linked to mesothelioma (Rizzo et
al. 2001), and many more. The mechanisms responsible for
the malignant transformation in cases of long-lasting viral
infection differ according to the particular virus and cancer
and have been extensively studied. An established associa-
tion between viral infection and cancer may lead the way for
development of a vaccine which could prevent both the
infection as well as the malignant transformation. Incorpora-
tion of viral DNA may interfere with the normal sequence of
human DNA bases, in a genetic manner, or cause secondary
epigenetic changes such as gene promoter methylation or
histone acetylation. Activation of oncogenes or silencing of
tumor suppressor genes may be the result of long lasting
inflammation. These gene products enhance proliferation and
inhibit apoptosis and differentiation, driving the cells towards
carcinogenesis.
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DOI 10.1007/s13148-010-0013-3Colorectal cancer is the second leading cause of cancer
mortality in the USA. Chromosomal instability has been
established as the key mechanistic component of cancer
development (Fearon and Vogelstein 1990). Later, it was
found that CRC results not only from the progressive
accumulation of genetic alteration, but also from epigenetic
changes (Lengauer et al. 1997). Three main pathways have
been described: chromosomal instability (CIN), micro-
satellite instability (MSI), and CpG island methylation
phenotype (CIMP; Boland and Goel 2010).
Hypermethylation in CRC
Microsatellite instability is involved in the genesis of about
15% of CRCs (Ionov et al. 1993; Thibodeau et al. 1993a;
Aaltonen et al. 1993). The multiple errors in repetitive
DNA sequences (microsatellites) result from a failure of the
DNA mismatch repair system to edit errors made during
DNA replication (Carethers and Boland 2003). This system
is inactivated either by hypermethylation of the promoter,
which silences gene transcription of hMLH1 (epigenetic
phenomenon in sporadic CRC), or because of germ-line
mutations (Herman et al. 1998; Lynch et al. 1993). Other
genes of the mismatch repair family, such as MSH2,
MSH6, and PMS2 may be inactivated by genetic processes,
and cause Lynch syndrome. 5′ Cytosine methylation of
CpG dinucleotide is the only known epigenetic modifica-
tion of DNA. DNA methylation is mediated by DNA
methyltransferase catalyzing the transfer of a methyl group
from methyl donor S-adenosil-methyonine to 5′ cytosine
postponed by guanine and forming methylcytosine (Lyko et
al. 1999; Robert et al. 2003). The overall frequency of CpG
dinucleotides is relatively low in the human genome and
accounts for approximately 1% of total DNA bases (Ehrlich
et al. 1982). However, up to 60% of genes have a 5′
promoter region with 0.3–2 kb stretches of DNA called
“CpG Island” (Bird 1986). The great majority of CpG
dinucleotides which are not associated with CpG islands are
heavily methylated; however, CpG dinucleotides in CpG
islands of promoter regions are usually unmethylated,
whether or not the gene is being transcribed (Antequera
and Bird 1993).
Cancer gene genomes simultaneously show global hypo-
methylation, specific promoter hypermethylation of tumor
suppressorgenes,andhypomethylationofoncogenes(Gaudet
et al. 2003;E d e ne ta l .2003; Greger et al. 1989). In addition
to DNA methylation, common epigenetic changes in cancer
include histone modification by acethylation (Jenuwein and
Allis 2001).
The methyl groups do not affect base pairing and are
therefore not hereditary. DNA methylation inhibits tran-
scription by interfering with transcriptional initiation. Some
of transcription factors cannot bind to DNA with methyl-
ated CpG Island to start transcription (Prendergast and Ziff
1991). Additionally, methylated DNA has general effect on
chromatin. Methyl cytosine binding proteins (MBPs) may
recognize and bind to methylated DNA. MBPs are part of
complexes containing histone deacetylases that inactivate
chromatin configuration around gene and silenced gene
expression by exclusion of transcriptional factors (Nan et
al. 1998).
Tumors with high-frequency microsatellite instability
tend to be diploid to possess a mucinous histology and to
have a surrounding lymphoid reaction. They are more
prevalent in the proximal colon, have a rapid (2–3 years)
progression from adenomatous polyp to cancer, and are
insensitive to 5-fluoro-uracil-based chemotherapy. Never-
theless, they are associated with longer survival than stage-
matched tumors with microsatellite stability (Lothe et al.
1993; Gryfe et al. 2000; Halling et al. 1999; Thibodeau et
al. 1993b; Lukish et al. 1998; Wright et al. 2000). Deng and
colleagues demonstrated that, in CRC, regional hyper-
methylation and global hypomethylation are associated
with altered chromatin conformation and histone acetyla-
tion, which have a causal correlation with MSI and CIN,
respectively (Deng et al. 2006). MSI cancers had closed
chromatin conformation and low levels of histone acetyla-
tion. Gene silencing is mediated by genetic processes, such
as mutation, deletion, or insertion of nucleotides or by
epigenetic mechanisms such as methylation of the CpG
Island in a gene promoter by the enzyme DNA methyl-
transferase. Recently, microRNAs (miRNAs) were found to
regulate gene transcription. This group of substances may
decrease or increase proliferation by silencing oncogenes or
tumor suppressor genes. Whether CpG island hypermethy-
lation constitutes a mechanism for miRNA silencing, and
its role in the development of cancer remains unexplored.
Balaguer and colleagues demonstrated that epigenetic
silencing of miR-137 is an early event in colorectal
carcinogenesis (Balaguer et al. 2010).
JC virus infection and hMLH1 hypermethylation
in CRC
Some oncoviruses, including JC virus, may initiate carci-
nogenesis by epigenetic modification of different onco-
genes. JC virus, a small non-enveloped negatively
supercoiled 5,130 bp dsDNA virus, is a member of the
polyomavirus family, which includes BK virus, SV40, and,
recently described, KI virus, WU virus, and MC virus
(White and Khalili 2004; Allander et al. 2007; Gaynor et al.
2007; Feng et al. 2008). JCV was first isolated in 1971
from the brain of a patient (John Cunningham) with
Hodgkin's lymphoma who developed progressive multifo-
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contains only six genes which encode the T- and t-antigens,
three viral capsid proteins (VP1-3), and an agnoprotein
involved in viral assembly. The T-Ag takes up over half of
the viral genome (Raj et al. 1998). With most humans
subclinically infected during childhood, this virus is
ubiquitous. Over 70% of adults possess neutralizing anti-
bodies to the virus, some 50% of adults shed JCV DNA in
the urine (Kitamura et al. 1994; Rossi et al. 2007). Several
studies suggest that JCV establishes latency in B lympho-
cytes (Monaco et al. 1996; Sabath and Major 2002);
however, the viral genome has also been detected in tissue
samples from brain, lung, spleen, liver, tonsils, and stomach
to colon.
JC virus is a candidate etiologic factor for sporadic CRC
(Niv et al. 2004). It may act by stabilizing β-catenin,
facilitating its entrance to the cell nucleus and starting
proliferation and cancer formation. Diploid CRC cell lines
transfected with JCV-containing plasmids developed CIN
(Niv et al. 2004). This result provided direct experimental
evidence for the ability of T-Ag to induce CIN in the
genome of colonic epithelial cells. The association of
hMLH1 promoter methylation and tumor positivity for JC
virus in CRC was recently documented (Goel et al. 2006).
JC virus T-Ag DNA sequences found in 77% of CRCs were
associated with promoter methylation of multiple genes
(Fig. 1). hMLH1 was methylated in 25 out of 80 CRC
patients positive for T-Ag (31%) in comparison with only
one out of 11 negative cases (9%). The latter patient was
microsatellite-stable. This observation is somewhat unex-
pected since, in this case, suppression of DNA repair by
silencing hMLH1 gene should be sufficient to cause
genomic instability and uncontrolled proliferation. We
confirmed this observation in a small sample of Israeli
patients (Niv et al. 2010). In this paper, we looked at both
JCV T-Ag in the CRC tissue and hMLH1 promoter
methylation in different ethnic groups in Israel with
different incidences of CRC. We found 83.3% positivity
of the tumors for JCV T-Ag, which is very similar to that in
previous publications (Laghi et al. 1999; Ricciardiello et al.
2003). Unexpectedly, we demonstrated hMLH1 promoter
methylation only in JCV T-Ag-positive tumors.
Nosho et al. (2009), in large study that included 766
patients with sporadic colorectal cancer, investigated the
correlation between expression of T-Ag in tumor tissue and
different molecular alterations (MSI, CIMP, CIN, loss of
heterozygosity of different loci, BRAF and KRAS muta-
tion, p53, b-catenin, cyclin D1, and cyclooxygenase-2
expression). In this study, JCV T-Ag was demonstrated in
35% of tumors, but, in contrast to results of Goel and
colleagues, expression of T-Ag was inversely associated
with MSI and CIMP. In multivariate logistic regression
analysis, JCV T-Ag expression was independently associ-
ated with p53 expression and CIN. In other study, Nosho et
al. (2008) investigated the association between JCV T-Ag
expression and methylator phenotype in 50 cases of
colorectal adenoma. T-Ag expression was demonstrated in
16 (32%) of cases, and the proportion of positive cases
increased progressively from unmethylated cases to CIMP-
low and CIMP-high.
Possible mechanisms of epigenetic processes induced
by chronic viral infection in cancer
An association between methylation and exposure to
carcinogens such as viruses has been observed before but
has not led to mechanistic insights into the process (Boland
et al. 2005; Shen et al. 2002). Human papillomavirus
chronic infection is associated with methylation of several
genes involved in carcinogenesis such as APC, CDKN2A,
PTEN, and others (Whiteside et al. 2008). Similarly, in
nasopharyngeal carcinoma associated with Epstein-Barr
virus (EBV), hypermethylation of certain cellular promoters
is attributed to the up-regulation of DNA methyltransfer-
ase1 (DNMT1) by the viral oncoprotein LMP1 via JNK/
AP1-signaling (Niller and Wolf 2009). The primary
molecular abnormality in EBV-associated gastric cancer is
global CpG Island methylation in the promoter region of
many cancer-related genes (Fukayama 2010). Viral latent
membrane protein 2A up-regulates cellular DNMT1
through phosphorylation of STAT3 and hypermethylation
and silencing of the tumor suppressor gene, PTEN.
Increased DNMT1 also caused methylation of E-cadherin,
hMLH1, and THBS-1 genes, and was associated with poor
prognosis (Etoh et al. 2004). Studying adenovirus type 12
oncogenesis in the hamster model, Doerfler et al. demon-
strated significant alteration in DNA methylation patterns























Fig. 1 Working hypothesis: JC virus T-Ag initiates proliferation
through WNT signaling or hypermethylation of hMLH1
Clin Epigenet (2011) 2:1–5 32009). Foreign DNA may cause extensive methylation in
cellular genome segments even at loci remote from the site
of insertion. In addition, down-regulation of microRNA by
viral component can induce aberrant DNA methylation by
targeting DNA methyltransferase 1, as demonstrated in
hepatitis B virus-related hepatocellular carcinoma, in this
case, miR-152 (Huang et al. 2010).
Conclusion
JC virus can mediate both CIN and aberrant methylation in
CRC. Like other viruses, chronic infection with JCV may
induce CRC by different mechanisms that should be further
specified. Gene promoter methylation induced by JCV may
be an important process in CRC and the polyp-carcinoma
sequence. Further research in this field is needed, looking at
a possible association between HNPCC tumors and JCV,
the presence of JCV in normal mucosa of cancer-free
patients, association between JCV with prognosis, and
survival in CRC cases of CIN, CIMP, and MSI pathways.
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